CollPlant Biotechnologies...

NASDAQ: CLGN · Real-Time Price · USD
2.48
-0.13 (-4.98%)
At close: Aug 15, 2025, 3:06 PM

CollPlant Biotechnologies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
515K 10.96M 299K 15.64M
Cost of Revenue
1.63M 1.99M 400K 2M
Gross Profit
-1.11M 8.97M -101K 13.64M
Operating Income
-17.25M -7.51M -17.1M 65K
Interest Income
738K 788K 321K 219K
Pretax Income
-16.61M -7.02M -16.93M 237K
Net Income
-16.61M -7.02M -16.75M 409K
Selling & General & Admin
5.63M 6M 6.74M 5.94M
Research & Development
10.52M 10.48M 10.26M 7.63M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
16.14M 16.48M 17M 13.57M
Interest Expense
17K 10K 34K 37K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
17.77M 18.47M 17.4M 15.58M
Income Tax Expense
n/a n/a -172K -172K
Shares Outstanding (Basic)
11.45M 11.39M 11.03M 9.97M
Shares Outstanding (Diluted)
11.45M 11.39M 11.03M 11.97M
EPS (Basic)
-1.45 -0.62 -1.52 0.04
EPS (Diluted)
-1.45 -0.62 -1.52 0.03
EBITDA
-16.21M -6.41M -16.02M 838K
EBIT
-17.25M -7.51M -17.1M 65K
Depreciation & Amortization
1.04M 1.1M 1.08M 773K